SWOT Analysis for Brawn Biotech Ltd.

Companies with no Debt
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Degrowth in Revenue and Profit
Declining profits every quarter for the past 2 quarters
Low Piotroski Score : Companies with weak financials
Fall in Quarterly Revenue and Net Profit (YoY)
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
Top Losers
Declining profitability: Falling ROCE
Stocks Underperforming their Industry Price Change in the Quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)

Brawn Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats